BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heier MS, Jansson TS, Gautvik KM. Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy. J Clin Sleep Med 2011;7:653-8. [PMID: 22171205 DOI: 10.5664/jcsm.1474] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Jacob L, Dauvilliers Y. La narcolepsie avec cataplexie : une maladie auto-immune ? Med Sci (Paris) 2014;30:1136-43. [DOI: 10.1051/medsci/20143012017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
2 van Holst RJ, van der Cruijsen L, van Mierlo P, Lammers GJ, Cools R, Overeem S, Aarts E. Aberrant Food Choices after Satiation in Human Orexin-Deficient Narcolepsy Type 1. Sleep 2016;39:1951-9. [PMID: 27568806 DOI: 10.5665/sleep.6222] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
3 Overeem S, Reading P, Bassetti CL. Narcolepsy. Sleep Medicine Clinics 2012;7:263-81. [DOI: 10.1016/j.jsmc.2012.03.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bornstein A, Hedström A, Wasling P. Actigraphy measurement of physical activity and energy expenditure in narcolepsy type 1, narcolepsy type 2 and idiopathic hypersomnia: A Sensewear Armband study. J Sleep Res 2021;30:e13038. [PMID: 32281246 DOI: 10.1111/jsr.13038] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kim H, Song JH, Kim TW, Kim SM, Um YH, Oh JH, Cho IH, Hong SC. Comorbidity of Narcolepsy and Obstructive Sleep Apnea: A Case Report. Sleep Med Res 2018;9:124-7. [DOI: 10.17241/smr.2018.00297] [Reference Citation Analysis]
6 Berteotti C, Silvani A. The link between narcolepsy and autonomic cardiovascular dysfunction: a translational perspective. Clin Auton Res 2018;28:545-55. [DOI: 10.1007/s10286-017-0473-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
7 Dunietz GL, Vanini G, Shannon C, O'Brien LM, Chervin RD. Associations of plasma hypocretin-1 with metabolic and reproductive health: Two systematic reviews of clinical studies. Sleep Med Rev 2020;52:101307. [PMID: 32259696 DOI: 10.1016/j.smrv.2020.101307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Mohammadi S, Moosaie F, Saghazadeh A, Mahmoudi M, Rezaei N. Metabolic profile in patients with narcolepsy: a systematic review and meta-analysis. Sleep Med 2021;81:268-84. [PMID: 33740593 DOI: 10.1016/j.sleep.2021.02.040] [Reference Citation Analysis]
9 Cremaschi RC, Hirotsu C, Tufik S, Coelho FM. Narcolepsy type 1 and type 2 - a 10-year follow-up: body mass index and comorbidities. Sleep Med 2017;32:285-6. [PMID: 28065686 DOI: 10.1016/j.sleep.2016.12.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
10 Rives-Lange C, Karsenty A, Chantereau H, Oderda L, Dubern B, Lecendreux M, Tounian P. [Narcolepsy in sleepy obese children. Two case reports]. Arch Pediatr 2016;23:603-6. [PMID: 27133373 DOI: 10.1016/j.arcped.2016.03.012] [Reference Citation Analysis]
11 Zink AN, Perez-Leighton CE, Kotz CM. The orexin neuropeptide system: physical activity and hypothalamic function throughout the aging process. Front Syst Neurosci 2014;8:211. [PMID: 25408639 DOI: 10.3389/fnsys.2014.00211] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
12 Black SW, Yamanaka A, Kilduff TS. Challenges in the development of therapeutics for narcolepsy. Prog Neurobiol 2017;152:89-113. [PMID: 26721620 DOI: 10.1016/j.pneurobio.2015.12.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
13 Sahni AS, Carlucci M, Malik M, Prasad B. Management Of Excessive Sleepiness In Patients With Narcolepsy And OSA: Current Challenges And Future Prospects. Nat Sci Sleep 2019;11:241-52. [PMID: 31695533 DOI: 10.2147/NSS.S218402] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Jennum P, Mayer G, Ju YE, Postuma R. Morbidities in rapid eye movement sleep behavior disorder. Sleep Med 2013;14:782-7. [PMID: 23375425 DOI: 10.1016/j.sleep.2012.11.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
15 Frauscher B, Ehrmann L, Mitterling T, Gabelia D, Gschliesser V, Brandauer E, Poewe W, Högl B. Delayed diagnosis, range of severity, and multiple sleep comorbidities: a clinical and polysomnographic analysis of 100 patients of the innsbruck narcolepsy cohort. J Clin Sleep Med 2013;9:805-12. [PMID: 23946711 DOI: 10.5664/jcsm.2926] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 6.4] [Reference Citation Analysis]
16 Ohayon MM, Black J, Lai C, Eller M, Guinta D, Bhattacharyya A. Increased mortality in narcolepsy. Sleep 2014;37:439-44. [PMID: 24587565 DOI: 10.5665/sleep.3470] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
17 Hayakawa K, Sakamoto Y, Kanie O, Ohtake A, Daikoku S, Ito Y, Shiota K. Reactivation of hyperglycemia-induced hypocretin (HCRT) gene silencing by N-acetyl-d-mannosamine in the orexin neurons derived from human iPS cells. Epigenetics 2017;12:764-78. [PMID: 28762874 DOI: 10.1080/15592294.2017.1346775] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
18 Mohammadi S, Dolatshahi M, Zare-shahabadi A, Rahmani F. Untangling narcolepsy and diabetes: Pathomechanisms with eyes on therapeutic options. Brain Research 2019;1718:212-22. [DOI: 10.1016/j.brainres.2019.04.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
19 Jennum P, Ibsen R, Knudsen S, Kjellberg J. Comorbidity and mortality of narcolepsy: a controlled retro- and prospective national study. Sleep 2013;36:835-40. [PMID: 23729926 DOI: 10.5665/sleep.2706] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 9.0] [Reference Citation Analysis]
20 Depner CM, Stothard ER, Wright KP Jr. Metabolic consequences of sleep and circadian disorders. Curr Diab Rep 2014;14:507. [PMID: 24816752 DOI: 10.1007/s11892-014-0507-z] [Cited by in Crossref: 191] [Cited by in F6Publishing: 174] [Article Influence: 23.9] [Reference Citation Analysis]
21 Kotagal S. Treatment of dyssomnias and parasomnias in childhood. Curr Treat Options Neurol 2012;14:630-49. [PMID: 23011807 DOI: 10.1007/s11940-012-0199-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]